| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| foundation medicine ngs | 1.11 | 0.6 | 5810 | 97 | 23 |
| foundation | 0.34 | 0.9 | 7363 | 69 | 10 |
| medicine | 0.52 | 0.9 | 3429 | 5 | 8 |
| ngs | 1.88 | 0.7 | 5060 | 54 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| foundation medicine ngs | 0.38 | 0.4 | 6188 | 91 |
| foundation medicine ngs testing | 0.11 | 0.9 | 7038 | 53 |
| ngs testing foundation one | 0.48 | 0.5 | 2620 | 1 |
| fda approved ngs tests | 1.09 | 0.2 | 8557 | 74 |
| ngs testing in oncology | 1.15 | 0.8 | 8373 | 59 |
| ngs testing for cancer | 1.76 | 1 | 8610 | 73 |
| foundation medicine genomic testing | 0.87 | 0.5 | 982 | 25 |
PATIENT INFORMATION HERE. Foundation Medicine, The Molecular Information Company, is connecting physicians and their patients to the latest cancer treatment approaches and making precision medicine a reality for thousands. Our portfolio of genomic tests is the leading platform for comprehensive genomic profiling.
How are Foundation Medicine's genomic profiling services supported?Our services are supported by a large and growing body of clinical evidence with over 500 publications since the founding of Foundation Medicine. 15-16 The validations of Foundation Medicine's comprehensive genomic profiling services are published in top-tier peer-reviewed journals. 4-7
What is FoundationOne Liquid?FoundationOne Liquid is the first and only liquid biopsy test to show prospective clinical utility in a global, registrational trial for patients with newly diagnosed, metastatic non-small cell lung cancer (NSCLC).
What is FoundationOne CDx?Overview What is FoundationOne CDx? FoundationOne CDx is the first FDA-approved tissue-based broad companion diagnostic (CDx) that is clinically and analytically validated for all solid tumors.
